Learning Objectives

  • Utilize updated criteria and guidelines to accurately diagnose atopic dermatitis (AD) and assess severity
  • Elucidate the limitations of currently available therapies in addressing underlying AD pathophysiology
  • Evaluate recent clinical evidence on the utility of approved and emerging biologic agents to address the underlying pathophysiology of AD
  • Discuss strategies that will improve patient satisfaction with treatment and reduce the burden of comorbidities